
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Lung cancer physical examination
Introduction
Overview
Overview
Common physical examination findings of lung cancer include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea.
Physical Examination
Physical Examination
Common physical examination findings of lung cancer include decreased/absent breath sounds, pallor, low-grade fever, and tachypnea.[1][2][3][4][5][6][7]
Appearance of the Patient
Vital Signs
- Vital signs are generally within normal limit, but patients with severe disease may present with:
- Low-grade fever
- Decreased SPO2
- Tachypnea
- Tachycardia
- Hypotension
Skin
HEENT
Neck
- Neck examination of patients with lung cancer is usually normal.
Lungs
- Decreased/absent breath sounds
Heart
- Cardiovascular examination of patients with lung cancer is usually normal.
Abdomen
Back
- Back examination of patients with lung cancer is usually normal.
Genitourinary
- Genitourinary examination of patients with lung cancer is usually normal.
Neuromuscular
- Bone pain
- Fractures (usually in the vertebrae, femur, pelvic bones, and the ribs)
- Cranial nerve palsies
Extremities
- Clubbing of fingers
- Swelling of hands and feet
- Weakness
- Hemiplegia
- Shoulder pain (caused by a Pancoast tumor)
- Thinning arms and legs
References
References
- β Degner, Lesley F.; Sloan, Jeffrey A. (1995). “Symptom distress in newly diagnosed ambulatory cancer patients and as a predictor of survival in lung cancer”. Journal of Pain and Symptom Management. 10 (6): 423β431. doi:10.1016/0885-3924(95)00056-5. ISSNΒ 0885-3924.
- β Feinstein AR, Wells CK (1990). “A clinical-severity staging system for patients with lung cancer”. Medicine (Baltimore). 69 (1): 1β33. PMIDΒ 2299974.
- β Chute CG, Greenberg ER, Baron J, Korson R, Baker J, Yates J (1985). “Presenting conditions of 1539 population-based lung cancer patients by cell type and stage in New Hampshire and Vermont”. Cancer. 56 (8): 2107β11. PMIDΒ 2992757.
- β Hirshberg B, Biran I, Glazer M, Kramer MR (1997). “Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital”. Chest. 112 (2): 440β4. PMIDΒ 9266882.
- β Kuo CW, Chen YM, Chao JY, Tsai CM, Perng RP (2000). “Non-small cell lung cancer in very young and very old patients”. Chest. 117 (2): 354β7. PMIDΒ 10669674.
- β Lepper PM, Ott SR, Hoppe H, Schumann C, Stammberger U, Bugalho A, Frese S, SchmΓΌcking M, Blumstein NM, Diehm N, Bals R, Hamacher J (2011). “Superior vena cava syndrome in thoracic malignancies”. Respir Care. 56 (5): 653β66. doi:10.4187/respcare.00947. PMIDΒ 21276318.
- β Buccheri, G. (2004). “Lung cancer: clinical presentation and specialist referral time”. European Respiratory Journal. 24 (6): 898β904. doi:10.1183/09031936.04.00113603. ISSNΒ 0903-1936.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy M.D Dildar Hussain, MBBS [2]
